PegBio (HKG:2565) said its cornerstone investor Yizekangrui Medical (HK) agreed to continue holding on to the company's shares for a further four months, according to a Hong Kong bourse filing Monday.
Yizekangrui Medical bought 9.6 million H shares of the company during its IPO and agreed to hold the stocks under a lock-up period expiring Dec. 31.
The investor has agreed to extend the lock-up period to April 30 and may continue to hold on to the shares as it reviews the company's performance, PegBio said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments